Wegovy is semaglutide (Ozempic) with doses up to 2.4 mg per week approved for obesity.

“I think a higher dose was actually approved uh just last year okay now fast forward to I think it was June of 21. spring of 21 thereabouts the study came out I think in April of 21 that looked at uh semi-glue tied it was actually using ozempic but the indication was in treating obesity without diabetes that's the study that we that that we talked about that at length in the previous AMA uh and we will touch on it briefly today but nevertheless that led to the approval of a new drug called wigovi which is of course the exact same drug”